FIELD: medicine.
SUBSTANCE: invention relates to medicine, and is intended for treatment of arterial hypertension at the background of metabolic syndrome. Level of cortisol in blood and heart rate (HR) are measured. If cotrisolemia is higher than 800 nmol/l and higher, HR being more than 80 beats per minute at rest in day hours, moxonidine is administered. Dose is 0.2-0.6 mg per day.
EFFECT: method makes it possible to correct arterial hypertension and insulin-resistance, increase arterial hypertension therapy efficiency at background of metabolic syndrome, and reduce risk of mortality from cardio-vascular diseases.
2 dwg, 7 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES AND REPRODUCTIVE DISORDERS IN FEMALES AT AGE OF 18-35 YEARS OLD SUFFERING METABOLIC DISORDERS | 2013 |
|
RU2527358C1 |
| METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
| METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD FOR METABOLIC SYNDROME CORRECTION WITH USE OF MARE'S MILK AND HYPOBAROTHERAPY | 2012 |
|
RU2472514C1 |
| METHOD OF TREATING AND/OR PREVENTION OF EXCESSIVE BODY WEIGHT AND/OR OBESITY AND/OR METABOLIC DISORDERS | 2008 |
|
RU2403038C2 |
| METHOD FOR TREATING PATIENTS WITH METABOLIC SYNDROME | 2017 |
|
RU2666288C1 |
| METHOD OF DIAGNOSING METABOLIC SYNDROME | 2010 |
|
RU2444298C1 |
